The recent data on the ThDP-mediated antiproliferative effect in a NSCLC cell line A549 [28] coupled to metabolic reprogramming of these cells [47], may therefore involve also ERO1A, whose expression is decreased by thiamine, as shown in our current work. The gene discussed is ERO1A; the disease is non-small cell lung carcinoma.